GC Content and Mappability Bias in Chromatin Data

Why Sequence Composition Matters

Chromatin-sequencing counts are not determined by chromatin state alone. A DNA fragment must be generated, survive library preparation and sequencing, and align to the reference before it contributes to coverage. GC content can affect amplification and sequencing efficiency; repetitive or otherwise ambiguous sequence can reduce the chance that a read maps uniquely to the intended region. These effects can make two regions with the same underlying chromatin signal yield different counts.

This matters when interpreting both enrichment against a control and differences in accessibility or histone-mark signal across conditions. A sequence-related coverage difference is not automatically a biological difference. The key diagnostic question is whether technical coverage depends on GC content or mappability, and whether that dependence differs across the samples being compared.

GC-dependent coverage is not necessarily a simple monotone trend. Depending on library preparation and sequencing, coverage can be depressed at one or both extremes of GC content, or vary in another smooth pattern. Mappability is also not a direct measurement of chromatin: it describes how distinguishable a sequence is from other sequences under the chosen mapping procedure. These properties should be computed from the reference sequence and the analysis definitions, not inferred from a region’s observed chromatin count alone.

A Model for Observed Coverage

Let \(Y_{ij}\) denote the number of usable reads assigned to region \(i\) in sample \(j\). A useful conceptual model separates biological abundance from technical opportunity. Let \(L_j\) represent the sample’s sequencing depth or size factor, \(a_{ij}\) the underlying biological signal, and \(q_j(g_i)\) the relative GC-dependent efficiency in sample \(j\). A simplified mean model is

where \(\ell_i\) is the region’s effective length under the counting definition. The model is an approximation: alignment rules, fragment distributions, duplicate handling, and assay chemistry can add further structure. For overdispersed region counts, a common working assumption is a negative binomial distribution with mean \(\mu_{ij}=E(Y_{ij})\) and variance \(\mu_{ij}+\phi_i\mu_{ij}^2\), where \(\phi_i\) is a dispersion parameter. In practice, count models also require appropriate normalization and a design that represents the biological comparison.

This factorization clarifies two distinct cases. If \(q_j(g_i)\) is effectively the same across samples, its effect is shared for a given region. In a within-region condition contrast, that common multiplicative factor can cancel from the expected ratio. It can still affect precision: low effective coverage means less information, and low mappability can make counts untrustworthy. If the GC response differs by sample, and the difference aligns with condition or batch, the technical factor need not cancel and can imitate a biological contrast.

Worked Examples of Bias and Correction

Why Shared Bias May Cancel—and When It Does Not

For a fixed region, suppose the expected counts in two conditions are \(L_A c_i a_{iA}\) and \(L_B c_i a_{iB}\), where \(c_i=\ell_i m_i q(g_i)\) is a shared sequence-related factor. After accounting for library sizes, the expected ratio is

This cancellation is the justification for not treating every GC or mappability difference as an automatic confounder of every differential test. It depends on the factor being common across the compared samples and on the region being measured comparably. It does not imply equal precision: if \(c_i\) is small, both expected counts may be small, uncertainty increases, and tests may have little power.

The cancellation fails if the effective factor differs across conditions. For example, a condition-specific GC response can arise from different library preparation, sequencing, or processing characteristics. If those characteristics are systematically associated with condition, a technical contrast may be mistaken for a biological one. For assay-versus-control enrichment, even libraries from the same sample can have distinct preparation and coverage responses, so their ratio may retain technical structure.

Diagnostics Before Choosing a Correction

A correction should respond to evidence of a technical relationship, not simply to the fact that GC content varies across the genome. Useful checks include plotting normalized coverage against GC content separately by sample and assay, examining the curve’s shape, and comparing curves across conditions or batches. A systematic trend in control or background regions can support a technical explanation, although the chosen regions must themselves be suitable as calibration data.

• Inspect GC curves by sample. Curves that differ in shape or amplitude across conditions raise concern that the bias will not cancel. A common trend across samples may still affect power and coverage comparisons.
• Check low-mappability regions. Compare coverage and the fraction of uniquely mapped reads across mappability strata. Unstable or unusually low coverage in poorly mappable regions supports filtering or cautious interpretation, not a claim of biological inaccessibility.
• Use controls thoughtfully. A control can reveal background behavior, but it is not guaranteed to share the assay library’s GC response. Compare relevant curves rather than assuming the ratio removes all technical effects.
• Check conclusions across reasonable choices. Compare results before and after filtering or correction, and examine whether the most prominent effects are concentrated in extreme-GC or low-mappability regions.

These checks are diagnostic, not proofs of causation. GC content can be associated with genuine genomic features, and biological signal may itself vary across GC strata. A curve estimated from regions with strong or condition-dependent signal can therefore mistake biology for technical bias. Correction is safest when the calibration set or model is justified independently of the effects being tested.

Region-Level Correction Strategies

There is no universally best correction. The choice depends on whether the main problem is unreliable mapping, a smooth GC-dependent efficiency trend, or unequal technical response between libraries.

A GC correction may be applied as an offset in a count model or as a transformation estimated from appropriate calibration data. In either case, the estimated response should be sample-aware when diagnostic curves differ by sample. For example, a region-level model might include a known effective-length term and an estimated GC term in the log mean, alongside the biological condition effect. The condition effect is interpretable only if the design can distinguish it from technical factors; if all samples in one condition share one preparation and all samples in the other condition share another, the two influences may be inseparable.

Filtering is often preferable to trying to rescue regions with extremely low mappability, because a correction cannot determine which ambiguous genomic location generated a read. Conversely, a region with adequate mappability but a modest, well-characterized GC trend may be retained and modeled. When conclusions depend strongly on a chosen smooth curve or calibration set, report that sensitivity rather than presenting a single corrected result as definitive.

Common Pitfalls and Limitations

• Assuming normalization removes sequence bias. Library-size normalization addresses differences in total usable counts, not necessarily region-specific GC response or mappability.
• Assuming every GC trend is technical. A coverage trend is a warning to investigate. If the calibration regions contain genuine signal, an automatic correction can attenuate biological differences.
• Treating low mappability as low accessibility. Poor mapping reduces measurement reliability; it is not evidence that chromatin is inaccessible.
• Applying one GC curve to unlike libraries. If the assay and control, or the compared conditions, have different response curves, a shared correction may leave residual bias.
• Overinterpreting corrected values. Adjusted counts depend on modeling choices and do not create information where reads were absent or ambiguously mapped.

The most defensible analysis combines sequence-aware diagnostics with a correction matched to the observed failure mode, then checks whether the scientific conclusions are robust. These steps can reduce technical distortion, but they cannot resolve a design in which condition and technical processing are completely confounded or guarantee that the remaining signal is biological.